BioScrip Buying Critical Homecare for $343 Million
BioScrip Inc. (Nasdaq: BIOS) has agreed to buy Critical Homecare Solutions from Kohlberg & Co. for $343.2 million in cash and stock. The deal also includes the issuance of 3.4 million BioScrip warrants with a $10 exercise price. Critical Homecare Solutions provides home infusion and home health agency services to patients suffering from chronic and acute medical conditions. It had agreed to be acquired for $534 million two years ago by a blank-check acquisition company called MBF Healthcare Acquisition Corp., but the deal was later renegotiated down to $469 million and then mutually-terminated.
25 January 2010•4 mins read
